Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Summary
To screen ischemic stroke patients likely to benefit from anticoagulation and compare the effectiveness and safety of anticoagulation versus antiplatelet therapy in preventing recurrent ischemic stroke within 3 months.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
680
Start Date
2026-08-15
Completion Date
2028-11-30
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
Rivaroxaban, or Edoxaban , or Apixaban , or Dabigatran
Rivaroxaban 15mg once daily, or Edoxaban 30mg once daily, or Apixaban 2.5mg twice daily, or Dabigatran 110mg twice daily
Aspirin
Aspirin 100mg once daily, or alternatives (Clopidogrel 75mg once daily, Ticagrelor 90mg twice daily, Cilostazol 100mg twice daily) if aspirin is unsuitable